Skip to content

    Atrial Fibrillation Health Center

    Font Size
    A
    A
    A

    New Blood Thinner Prevents Strokes in Heart Patients

    Study Shows Xarelto Works as Well as Warfarin in Preventing Strokes for Patients With Atrial Fibrillation
    By
    WebMD Health News
    Reviewed by Laura J. Martin, MD

    Aug. 10, 2011 -- The newly approved drug Xarelto appears to prevent strokes at least as well as the standard treatment warfarin in people who have a heart condition that puts them at high risk for blood clots, a study shows.

    Xarelto was approved by the FDA in July to prevent dangerous blood clots in people having hip and knee replacement surgery.

    Next month, a panel of experts will consider whether the agency should also approve its use as a once-daily treatment for atrial fibrillation.

    Atrial fibrillation causes the heart to pump in an irregular, uncoordinated way that may allow blood to pool and clot in its upper chambers. Those clots can travel to the brain, causing a stroke.

    Patients with atrial fibrillation are commonly prescribed the blood-thinning drug warfarin, which is also sold under the brand names Coumadin and Jantoven.

    "Warfarin, which we found in the '50s and '60s, is a very good drug in preventing stroke, but it's sometimes difficult to use," says study researcher Manesh R. Patel, MD, a cardiologist at Duke University.

    Because it works by blocking vitamin K, foods that are high in that nutrient, like dark leafy greens, can make warfarin less effective. A host of other medications including some antibiotics and painkillers can interact with the drug, blocking or enhancing its effect.

    Doctors typically require patients on warfarin to get monthly blood tests to make sure it's working properly and "not making the blood too thick or too thin, so to speak," Patel says.

    Comparing Xarelto to Warfarin

    A new study, published in The New England Journal of Medicine, tested Xarelto against warfarin in more than 14,000 patients with atrial fibrillation.

    The patients in the study were deemed to be at moderate to high risk of stroke, either because they'd had a stroke before or because they had heart failure, high blood pressure, diabetes, or they were older than age 75.

    Patients were randomly assigned to take either a daily dose of warfarin or Xarelto. To prevent people from knowing which treatment they were getting, both groups were also assigned to take a placebo pill.

    1 | 2 | 3

    Today on WebMD

    pacemaker next to xray
    Ablation, cardioversion, pacemaker, and more.
    stethoscope
    What you need to know.
     
    woman doing yoga
    Tips for easing stress.
    fish and vegetables
    How to eat to protect your heart.
     
    Omega 3 Overview Slideshow
    Slideshow
    At Risk for Heart Disease
    Article
     
    Recognizing Womens Heart Symptoms
    Article
    Simple Steps to Lower Cholesterol
    Slideshow
     

    Resolved To Quit Smoking
    Slideshow
    Lowering Blood Pressure Slideshow
    Slideshow
     
    Heart Disease And Ed
    Article
    Atrial fibrillation
    Slideshow